Search results
Found 6917 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Oxford medical researchers named NIHR Senior Investigators
Awards and Appointments General
9 March 2021
Five leading healthcare academics in Oxford have been named National Institute of Health Research (NIHR) Senior Investigators
Rare Disease Day 2021: Pandemic response prepares us for next major challenge
General Research
9 March 2021
Success in QS Subject Ranking
Awards and Appointments General
9 March 2021
Oxford Medical Sciences has come top in two subject areas in the latest and internationally-respected QS rankings.
Oxford vaccine creator Professor Sarah Gilbert awarded RSA Albert Medal
Awards and Appointments Coronavirus COVID-19 General Innovation Research
5 March 2021
Professor Sarah Gilbert has been awarded the Royal Society for Arts, Manufactures and Commerce’ (RSA) Albert Medal for her work on the Oxford vaccine.
PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine
Clinical Trials Coronavirus COVID-19 General Research
3 March 2021
From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.
Regular meat consumption linked with a wide range of common diseases
Research
2 March 2021
Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.
New data show vaccines reduce severe COVID-19 in older adults
Coronavirus COVID-19 Research
2 March 2021
New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.
Singula Bio, a new Oxford spin-out company - Cancer need not be fatal
General Innovation Research
25 February 2021
Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.
Call for Mentors: Council for At-Risk Academics (CARA)
25 February 2021
Major rise in public support for COVID vaccine – Oxford study
Coronavirus COVID-19 General Research
24 February 2021
More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.
Three ways virtual reality could transform mental health treatment
General Research
22 February 2021
Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests
Coronavirus COVID-19 General Research
22 February 2021
The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.
World’s largest clinical trial for COVID-19 treatments expands internationally
Clinical Trials Coronavirus COVID-19 General
18 February 2021
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.
Reprogramming tumour cells using an antimalarial drug
General Research
18 February 2021
Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.